Blood Pressure Variability and Plasma Biomarkers of Neuronal Injury and Alzheimer's Disease: A Clinic-Based Study of Patients with Diseases Along the Heart-Brain Axis
Publication date
2024
Authors
Heart-Brain Connection Consortium
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
Higher blood pressure variability (BPV) predisposes to cognitive decline. To investigate underlying mechanisms, we measured 24-h ambulatory BPV, nocturnal dipping and orthostatic hypotension in 518 participants with vascular cognitive impairment, carotid occlusive disease, heart failure, or reference participants. We determined cross-sectional associations between BPV indices and plasma biomarkers of neuronal injury (neurofilament light chain) and Alzheimer's disease (phosphorylated-tau-181 and Aβ42/Aβ40). None of the BPV indices were significantly associated with any of the biomarkers. Hence, in patients with diseases along the heart-brain axis, we found no evidence for an association between BPV and selected markers of neuronal injury or Alzheimer's disease.
Keywords
Alzheimer’s disease, amyloid, biomarkers, blood pressure, dementia, orthostatic hypotension, tau proteins, Geriatrics and Gerontology, Psychiatry and Mental health, Clinical Psychology, General Neuroscience, Journal Article
Citation
Heart-Brain Connection Consortium 2024, 'Blood Pressure Variability and Plasma Biomarkers of Neuronal Injury and Alzheimer's Disease : A Clinic-Based Study of Patients with Diseases Along the Heart-Brain Axis', Journal of Alzheimer's disease : JAD, vol. 99, no. 4, pp. 1207-1215. https://doi.org/10.3233/JAD-240119